CN101449163B - S100a12蛋白作为结肠直肠癌标记的用途 - Google Patents

S100a12蛋白作为结肠直肠癌标记的用途 Download PDF

Info

Publication number
CN101449163B
CN101449163B CN200780018059.1A CN200780018059A CN101449163B CN 101449163 B CN101449163 B CN 101449163B CN 200780018059 A CN200780018059 A CN 200780018059A CN 101449163 B CN101449163 B CN 101449163B
Authority
CN
China
Prior art keywords
colorectal cancer
protein
crc
marker
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN200780018059.1A
Other languages
English (en)
Chinese (zh)
Other versions
CN101449163A (zh
Inventor
N·威尔德
H·安德烈斯
U·加扎雷克
A·盖斯坦格
M·-L·哈格曼
J·卡尔
F·克劳斯
M·普费弗
W·罗林杰
M·塔克
M·蒂罗尔夫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of CN101449163A publication Critical patent/CN101449163A/zh
Application granted granted Critical
Publication of CN101449163B publication Critical patent/CN101449163B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57535—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the large intestine, e.g. colon, rectum or anus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4727—Calcium binding proteins, e.g. calmodulin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/795—Porphyrin- or corrin-ring-containing peptides
    • G01N2333/805—Haemoglobins; Myoglobins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205—Phosphotransferases in general
    • G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CN200780018059.1A 2006-05-19 2007-05-16 S100a12蛋白作为结肠直肠癌标记的用途 Expired - Fee Related CN101449163B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06010439.5 2006-05-19
EP06010439 2006-05-19
PCT/EP2007/004378 WO2007134779A1 (en) 2006-05-19 2007-05-16 Use of protein s100a 12 as a marker for colorectal cancer

Publications (2)

Publication Number Publication Date
CN101449163A CN101449163A (zh) 2009-06-03
CN101449163B true CN101449163B (zh) 2014-06-25

Family

ID=37087565

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200780018059.1A Expired - Fee Related CN101449163B (zh) 2006-05-19 2007-05-16 S100a12蛋白作为结肠直肠癌标记的用途

Country Status (15)

Country Link
US (3) US20090286328A1 (https=)
EP (1) EP2021794B8 (https=)
JP (1) JP4942813B2 (https=)
KR (1) KR101147586B1 (https=)
CN (1) CN101449163B (https=)
AT (1) ATE471512T1 (https=)
AU (1) AU2007251933B2 (https=)
BR (1) BRPI0711763A2 (https=)
CA (1) CA2651709A1 (https=)
DE (1) DE602007007209D1 (https=)
DK (1) DK2021794T3 (https=)
ES (1) ES2347485T3 (https=)
MX (1) MX2008014482A (https=)
PL (1) PL2021794T3 (https=)
WO (1) WO2007134779A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10957217B2 (en) 2006-08-25 2021-03-23 Ronald A. Weitzman Population-sample regression in the estimation of population proportions
US11151895B2 (en) * 2006-08-25 2021-10-19 Ronald Weitzman Population-sample regression in the estimation of population proportions
ATE521894T1 (de) * 2007-11-20 2011-09-15 Hoffmann La Roche Verfahren zur beurteilung von kolorektalem krebs anhand einer stuhlprobe durch verwendung einer marker-kombination aus calprotectin und einem hämoglobin/haptoglobin-komplex
JP5461201B2 (ja) * 2008-01-31 2014-04-02 学校法人慶應義塾 抗がん剤感受性の判定方法
EP2816122A1 (en) 2008-02-15 2014-12-24 Mayo Foundation For Medical Education And Research Detecting neoplasm from a stool sample
WO2015067913A1 (en) 2013-11-07 2015-05-14 Diagnodus Limited Biomarkers
CN103033623A (zh) * 2012-12-10 2013-04-10 天津市协和医药科技集团有限公司 人m2型丙酮酸激酶化学发光免疫分析试剂盒及制备方法
CA2902916C (en) 2013-03-14 2018-08-28 Mayo Foundation For Medical Education And Research Detecting neoplasm
CN104178562B (zh) * 2013-05-21 2018-11-09 生物梅里埃股份公司 一种大肠癌预后试剂盒
US10184154B2 (en) 2014-09-26 2019-01-22 Mayo Foundation For Medical Education And Research Detecting cholangiocarcinoma
US10435755B2 (en) 2015-03-27 2019-10-08 Exact Sciences Development Company, Llc Detecting esophageal disorders
CN114574585A (zh) 2015-08-31 2022-06-03 梅约医药教育及研究基金会 检测胃肿瘤
CN107271681A (zh) * 2017-06-05 2017-10-20 中国人民解放军沈阳军区总医院 血浆s100a12在st段抬高型心肌梗死早期诊断中的应用
AU2019252672B2 (en) 2018-04-12 2025-08-14 Board Of Regents, The University Of Texas System Biomarker for detecting cancer
WO2021015619A1 (en) * 2019-07-23 2021-01-28 Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Progression markers for colorectal adenomas
AU2020365127B2 (en) * 2019-10-18 2026-04-09 Exact Sciences Corporation Multiple analyte fecal antigen testing

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004079368A2 (en) * 2003-03-08 2004-09-16 Auvation Ltd Markers for colorectal cancer
WO2005054508A2 (en) * 2003-12-01 2005-06-16 Ipsogen Gene expression profiling of colon cancer by dna microarrays and correlation with survival and histoclinical parameters
WO2006012588A2 (en) * 2004-07-23 2006-02-02 Aspenbio, Pharma, Inc. Methods and devices for diagnosis of appendicitis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61137064A (ja) * 1984-12-07 1986-06-24 Fujirebio Inc 大腸癌の予備スクリ−ニング方法
DE3838900A1 (de) * 1988-11-17 1990-05-23 Scheefers Borchel Ursula Pyruvatkinase-isoenzym typ m2 (tumor m2-pk) spezifische antikoerper/verfahren zu deren herstellung und deren verwendung
JPH02193071A (ja) * 1989-01-20 1990-07-30 Green Cross Corp:The ハプトグロビン―ヘモグロビン複合体測定用試薬キット及びそれを用いるハプトグロビン―ヘモグロビン複合体の測定法
JPH08238090A (ja) * 1995-03-06 1996-09-17 Jiro Hitomi 新規カルシウム結合タンパク
US20030175713A1 (en) * 2002-02-15 2003-09-18 Clemens Sorg Method for diagnosis of inflammatory diseases using CALGRANULIN C
JP2004198419A (ja) * 2002-12-13 2004-07-15 Bayer Healthcare Llc Ｔｉｍｐ１を用いた検出方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004079368A2 (en) * 2003-03-08 2004-09-16 Auvation Ltd Markers for colorectal cancer
WO2005054508A2 (en) * 2003-12-01 2005-06-16 Ipsogen Gene expression profiling of colon cancer by dna microarrays and correlation with survival and histoclinical parameters
WO2006012588A2 (en) * 2004-07-23 2006-02-02 Aspenbio, Pharma, Inc. Methods and devices for diagnosis of appendicitis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Sieg等.Detection of colorectal neoplasms by the highly sensitive hemoglobin-haptoglobin complex in feces.《International Journal of Colorectal Disease》.1999,第14卷(第6期), *

Also Published As

Publication number Publication date
JP2009537798A (ja) 2009-10-29
AU2007251933A1 (en) 2007-11-29
MX2008014482A (es) 2008-11-27
WO2007134779A1 (en) 2007-11-29
DK2021794T3 (da) 2010-10-11
HK1133295A1 (en) 2010-03-19
BRPI0711763A2 (pt) 2011-12-06
EP2021794B1 (en) 2010-06-16
US20150192587A1 (en) 2015-07-09
EP2021794B8 (en) 2010-08-18
US20170115294A1 (en) 2017-04-27
DE602007007209D1 (de) 2010-07-29
ES2347485T3 (es) 2010-10-29
CN101449163A (zh) 2009-06-03
US20090286328A1 (en) 2009-11-19
KR20090007454A (ko) 2009-01-16
EP2021794A1 (en) 2009-02-11
AU2007251933B2 (en) 2011-05-12
JP4942813B2 (ja) 2012-05-30
PL2021794T3 (pl) 2010-12-31
KR101147586B1 (ko) 2012-08-23
CA2651709A1 (en) 2007-11-29
ATE471512T1 (de) 2010-07-15

Similar Documents

Publication Publication Date Title
CN101449163B (zh) S100a12蛋白作为结肠直肠癌标记的用途
CN100437115C (zh) 烟酰胺n-甲基转移酶作为结肠直肠癌标志的用途
JP2008502890A (ja) 結腸直腸癌のマーカーとしてのｃｂｐ２の使用
CN101680898A (zh) Timp-1作为结肠直肠癌标志的用途
JP4241822B2 (ja) 結腸直腸癌に対するマーカーとしてのタンパク質ｍａｓｐの使用
JP4673895B2 (ja) 直腸結腸癌用マーカーとしてのａｓｃの使用
US20060188949A1 (en) Use of protein PLST as a marker for colorectal cancer
JP4292208B2 (ja) 乳癌に対するマーカーとしてのタンパク質ｓｐｅｅの使用
CN1833170B (zh) 蛋白类蛋白酶体激活剂亚基3(pse3)作为结直肠癌标记物的用途
HK1133295B (en) Use of protein s100a12 as a marker for colorectal cancer
US20060194266A1 (en) Use of protein RLA-0 as a marker for colorectal cancer
US20070218510A1 (en) Use of protein PSA3 as a marker for colorectal cancer
WO2005015223A1 (en) Use of protein acidic ribosomal protein p0 (rla-0) as a marker for colorectal cancer
WO2005015232A1 (en) Use of protein proteasmose activator subunit 3 (pse3) as a marker for colorectal cancer
HK1142130A (en) Use of timp-1 as a marker for colorectal cancer
WO2005015230A1 (en) Use of protein psa3 as a marker for colorectal cancer

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1133295

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1133295

Country of ref document: HK

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140625

CF01 Termination of patent right due to non-payment of annual fee